SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹14 Cr | ₹1.71 Cr | ₹1.35 Cr | ₹2.46 Cr | ₹3.58 Cr |
What is the latest Total Non-Current Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹14 Cr |
| Mar2025 | ₹1.71 Cr |
| Mar2024 | ₹1.35 Cr |
| Mar2023 | ₹2.46 Cr |
| Mar2022 | ₹3.58 Cr |
How is Total Non-Current Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹14 Cr | 721.86 | |
| Mar2025 | ₹1.71 Cr | 27.12 | |
| Mar2024 | ₹1.35 Cr | -45.33 | |
| Mar2023 | ₹2.46 Cr | -31.13 | |
| Mar2022 | ₹3.58 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹8,155.8 Cr | -6.5% | -23.4% | 47.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -6.5% |
-23.4% |
47.4% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses